SMND-309, a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: Characterization and role

Brain Research

Volumn 1263, Issue , 2009, Pages 114-121

  Tian, Jingwei ^a,b   Fu, Fenghua ^a   Li, Guisheng ^a,b   Wang, Youlei ^c   Gao, Yubai ^b   Liu, Zhifeng ^a,b   Zhang, Shumin ^b  

^a YANTAI UNIVERSITY   (China)

^b Shandong Engineering Research Center for Nature Drug   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

(2E) 2 6 (E) 2 carboxylvinyl 2,3 dihydroxyphenyl 3 (3,4 dihydroxyphe nyl) propenoic acid; Cerebral ischemia; Mitochondrial; Neuroprotection; SMND 309

Indexed keywords

2 [6 (2 CARBOXYLVINYL) 2,3 DIHYDROXYPHENYL] 3 (3,4 DIHYDROXYPHENYL)PROPENOIC ACID; ADENOSINE TRIPHOSPHATE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; SALVIANOLIC ACID B DERIVATIVE; SMND 309; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BOLUS INJECTION; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ENERGY METABOLISM; ENZYME ACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CAFFEIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT; ENERGY METABOLISM; GLUTATHIONE PEROXIDASE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MALONDIALDEHYDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE; TIME FACTORS;

RATTUS;

EID: 62249093078     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.01.034     Document Type: Article

References (31)

1. Bi X.B., Deng Y.B., Gan D.H., and Wang Y.Z. Salvianolic acid B promotes survival of transplanted mesenchymal stem cells in spinal cord-injured rats. Acta Pharmacol. Sin. 29 (2008) 169-176
2. Casetta I., Govoni V., and Granieri E. Oxidative, stress, antioxidants and neurodegenerative diseases. Curr. Pharm. Des. 11 (2005) 2033-2052
3. Chen Y.H., Du G.H., and Zhang J.T. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol. Sin. 21 (2000) 463-466
4. Chen J., Wang F., Lee F.S., Wang X., and Xie M. Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis. Talanta 69 (2006) 172-179
5. De Cristóbal J., Cárdenas A., Lizasoain I., Leza J.C., Fernández-Tomé P., Lorenzo P., and Moro M.A. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke 33 (2002) 261-267
6. Du G.H., Qiu Y., and Zhang J.T. Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice. J. Asian Nat. Prod. Res. 2 (2000) 145-152
7. Durairajan S.S., Yuan Q., Xie L., Chan W.S., Kum W.F., Koo I., Liu C., Song Y., Huang J.D., Klein W.L., and Li M. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty. Neurochem. Int. 52 (2008) 741-750
8. Durukan A., Tatlisumak T., and Acute ischemic stroke. overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 87 (2007) 179-197
9. Guang H.M., and Du G.H. Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 542 (2006) 77-83
10. Ji X.Y., Tan B.K., and Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21 (2000) 1089-1094
11. Kaur P., Radotra B., Minz R.W., and Gill K.D. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology 28 (2007) 1208-1219
12. Kintner D.B., Fitzpatrick Jr. J.H., and Gilboe D.D. Hyperglycemic damage to mitochondrial membranes during cerebral ischemia, amelioration by platelet-activating factor antagonist BN 50739. J. Neurochem. 69 (1997) 1219-1227
13. Lang-Rollin I.C., Rideout H.J., Noticewala M., and Stefanis L. Mechanisms of caspase-independent neuronal death, energy depletion and free radical generation. J. Neurosci. 23 (2003) 11015-11025
14. Lay I.S., Chiu J.H., Shiao M.S., Lui W.Y., and Wu C.W. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med. 69 (2003) 26-32
15. Lay I.S., Hsieh C.C., Chiu J.H., Shiao M.S., Lui W.Y., and Wu C.W. Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in Sprague-Dawley rats. J. Surg. Res. 115 (2003) 279-285
16. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
17. Lin Y.L., Wu C.H., Luo M.H., Huang Y.J., Wang C.N., Shiao M.S., and Huang Y.T. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J. Ethnopharmacol. 105 (2006) 215-222
18. Liu C.L., Xie L.X., Li M., Durairajan S.S., Goto S., and Huang J.D. Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS ONE 2 (2007) e1321
19. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
20. Lowry O.H., Berger S.J., Carter J.G., Chi M.M., Manchester J.K., Knor J., and Pusateri M.E. Diversity of metabolic patterns in human brain tumors, enzymes of energy metabolism and related metabolites and cofactors. J. Neurochem. 41 (1983) 994-1010
21. Mastrocola R., Restivo F., Vercellinatto I., Danni O., Brignardello E., Aragno M., and Boccuzzi G. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J. Endocrinol. 187 (2005) 37-44
22. Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 (1999) 2752-2758
23. Tang M., and Zhang J. Prostate apoptosis response-4 involved in the protective effect of salvianolic acid B against amyloid beta peptide-induced damage in PC12 cells. Jpn. J. Pharmacol. 88 (2002) 422-427
24. Tang M.K., Ren D.C., Zhang J.T., and Du G.H. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 9 (2002) 405-409
25. Tang M., Feng W., Zhang Y., Zhong J., and Zhang J. Salvianolic acid B improves motor function after cerebral ischemia in rats. Behav. Pharmacol. 17 (2006) 493-498
26. Tian J., Fu F., Geng M., Jiang Y., Yang J., Jiang W., Wang C., and Liu K. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci. Lett. 374 (2005) 92-97
27. Tian J., Li G., Liu Z., and Fu F. Hydroxysafflor yellow a inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action. Pharmacology 82 (2008) 121-126
28. Tian J., Li G., Liu Z., Zhang S., Qu G., Jiang W., and Fu F. ND-309, a novel compound, ameliorates cerebral infarction in rats by antioxidant action. Neurosci. Lett. 442 (2008) 279-283
29. Trushina E., and McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145 (2007) 1233-1248
30. Zhan C., and Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol. Res. 53 (2006) 303-309
31. Zhao B.L., Jiang W., Zhao Y., Hou J.W., and Xin W.J. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem. Mol. Biol. Int. 38 (1996) 1171-1182